Ravikiran yerabolu

Company: Merck & Co

Job title: Associate Principal Scientist

Seminars:

Deep-Dive Workshop: Accomplishing Improved Encapsulation & Targeting of RNA Therapeutics by Uncovering Innovative Delivery Strategies for More Potent & Effective Therapies 11:00 am

A major bottleneck inhibiting the full potential of all RNA therapeutics is delivery. With self-amplifying and circular RNA payloads typically being larger than those of linear mRNA, this complicates their encapsulation. Furthermore, while current lipid nanoparticles (LNPs) have demonstrated safety and efficacy of mRNA vaccines, their use has been restricted to intramuscular administration. During this…Read more

day: Conference Day Two